These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3960014)

  • 21. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcific uremic arteriolopathy in association with low turnover uremic bone disease.
    Mawad HW; Sawaya BP; Sarin R; Malluche HH
    Clin Nephrol; 1999 Sep; 52(3):160-6. PubMed ID: 10499311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal surveys in renal osteodystrophy.
    Mohini R; Dumler F; Rao DS
    ASAIO Trans; 1991; 37(4):635-7. PubMed ID: 1768501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Physiopathology of renal osteodystrophy. I. Patients with kidney failure without dialysis].
    Fournier A; Bordier P; Weil B; Safar M; Idatte JM
    Presse Med (1893); 1971 Oct; 79(45):2017-21. PubMed ID: 5119047
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships between histomorphometric features of bone formation and bone cell characteristics in vitro in renal osteodystrophy.
    Marie PJ; Lomri A; de Vernejoul MC; Morieux C; Graulet AM; Guéris J; Llach F
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1166-73. PubMed ID: 2555383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic renal failure: diagnostic measures before parathyroidectomy.
    Dahl E; Nordal KP; Halse J
    Scand J Urol Nephrol; 1994 Sep; 28(3):291-4. PubMed ID: 7817173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.
    Goodman WG; Duarte ME
    Miner Electrolyte Metab; 1991; 17(4):221-32. PubMed ID: 1813784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on plasma parathyroid hormone levels and their relationship to bone histopathology among patients undergoing dialysis.
    Goodman WG
    Semin Dial; 2007; 20(1):1-4. PubMed ID: 17244110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between bone mineral density and secondary hyperparathyroidism bone disease].
    Ning JP; Sun M; Toru I; Etsuo Y
    Hunan Yi Ke Da Xue Xue Bao; 2000 Feb; 25(1):77-9. PubMed ID: 12212259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlations between osteodensitometry and parameters of uremic osteodystrophy].
    Sforzini S; Viganò MR; Beretta P; Rosa M; d'Amico P; Lomuscio G; Paesani R
    Minerva Med; 1985 Mar; 76(9-10):445-8. PubMed ID: 3982703
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
    Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rheumatologic and radiologic symptoms of secondary hyperparathyroidism: retrospective long-term study of 175 chronic hemodialysis patients].
    Mayet WJ; Hermann E; Wandel E; Elsen A; Schadmand S; Klose KJ; Poralla T; Meyer zum Büschenfelde KH; Köhler H
    Z Rheumatol; 1991; 50(5):313-9. PubMed ID: 1776368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
    Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.